Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective – prospective observational study – a cohort from 4 European countries

This publication has 21 references indexed in Scilit:

• Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
  New England Journal of Medicine, 2013
• Predicting life expectancy in patients with advanced incurable cancer: a review
  Journal of Supportive Oncology, 2013
• Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
  New England Journal of Medicine, 2012
• Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999–2006
  Breast Cancer Research and Treatment, 2011
• Abiraterone and Increased Survival in Metastatic Prostate Cancer
  New England Journal of Medicine, 2011
• Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999–2006
  Prostate Cancer and Prostatic Diseases, 2011
• Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)
  Journal of Thoracic Oncology, 2011
• The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain
  European Journal of Cancer Care, 2009
• Predictors of Survival in Patients With Bone Metastasis of Lung Cancer
  Clinical Orthopaedics and Related Research, 2008
• Mechanisms of Bone Metastasis
  New England Journal of Medicine, 2004